ArticleThe Journal of physiology2025
GsMTx-4 inhibits the exercise pressor reflex and the muscle mechanoreflex primarily through TRPC inhibition.
Article in The Journal of physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Liver Stiffness Rises Early in MASLD and Drives Inflammation, Lipid Dysmetabolism, and Fibrosis via Piezo1-YAP Mechanotransduction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Myophosphorylase Knock Out Prevents the Exaggerated Exercise Pressor Reflex in Rats With Simulated Peripheral Artery Disease.Acta physiologica (Oxford, England) · 2026Article
- Neutrophil Extracellular Traps in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Targets.Journal of inflammation research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Evidence suggests that Piezo 2 and TRPC6 channels play important roles in evoking the mechanical component of the exercise pressor reflex. However, the pharmacological tools used in previous studies, namely GsMTx-4 (Piezo 2) and SAR7334 (TRPC6), have potential overlapping effects. GsMTx-4, in particular, inhibits TRPC6 channels in addition to Piezo 2. Consequently, we determined in vivo the initial and combined effects of serial injection of GsMTx-4 and SAR7334 in evoking the mechanical component of the exercise pressor reflex in male and female decerebrated rats. In addition, in heterologous cells expressing Piezo 2 channels, we determined the effect of SAR7334 on the inward current evoked by membrane stretch. The exercise pressor reflex and the mechanoreflex were evoked by statically contracting and passively stretching the triceps surae muscles before and after injection of GsMTx-4 (51 ± 8µm) followed by SAR7334 (51 ± 8µm; n = 8-9) or after injection of SAR7334 (51 ± 8µm) followed by GsMTx-4 (51 ± 8µm; n = 8). In vivo, GsMTx-4 and SAR7334 inhibited the pressor and sympathetic nerve responses to passive stretch and static contraction when injected first. When GsMTx-4 was injected secondary to SAR7334, no reduction in blood pressure and sympathetic responses to static contraction or passive stretch was observed. In vitro, 1 µm of SAR7334 increased the inward current evoked by membrane stretch in heterologous cells expressing Piezo 2 (n = 6). In contrast, 4 µm increased the inward current in two cells, did not change the current in one cell and decreased the current in three cells. Our findings suggest that GsMTx-4 in our in vivo experiments antagonized TRPC as well as Piezo 2 channels. KEY POINTS: GsMTx-4 blocks both Piezo 2 channels and TRPC6 raising the possibility that its effects on the exercise pressor reflex and the mechanoreflex is mediated through TRPC6 inhibition. We determined the effects of GsMTx-4 alone, and after pre-treatment with a TRPC6 antagonist (SAR7334), to elucidate the potential overlapping effects of the drug on the exercise pressor reflex and the mechanoreflex. GsMTx-4 alone significantly inhibited the pressor and sympathetic responses to static contraction and passive stretch. However, when GsMTx-4 was injected after pre-treatment with a TRPC6 antagonist, the effects of GsMTx-4 were abolished. These results demonstrate that the effects of GsMTx-4 are mediated through TRPC6 channel inhibition and that the role played by Piezo 2 was previously overestimated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.